First Tracks Biotherapeutics is trading at $31.34 (-5.01%) as biotech-sector weakness coincides with the decline; no clear company-specific announcement explaining it surfaced in searched sources.

  • The XBI was reported down 3.17% on October 6; supplied sector context also indicates a 2.50% decline.
  • Recent company news found was older, while the broader market was higher.